Empirical Asset Management’s Charles River Laboratories CRL Stock Holding History

Empirical Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Buy	1,515 +7	+0.5%	+$1.25K	0.08%	290
2026 Q1	$260K	Hold	1,508	–	–	0.07%	318
2025 Q4	$301K	Sell	1,508 -5	-0.3%	-$907	0.08%	263
2025 Q3	$237K	Buy	1,513 +7	+0.5%	+$1.11K	0.07%	325
2025 Q2	$229K	Hold	1,506	–	–	0.07%	287
2025 Q1	$227K	Buy	1,506 +86	+6%	+$14.4K	0.08%	288
2024 Q4	$262K	Sell	1,420 -199	-12%	-$38.3K	0.09%	251
2024 Q3	$319K	Buy	1,619 +23	+1%	+$4.78K	0.11%	221
2024 Q2	$330K	Buy	1,596 +97	+6%	+$22K	0.12%	227
2024 Q1	$406K	Buy	+1,499	New	+$358K	0.2%	142

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Empirical Asset Management's CRL Position: Q2 2026 in Review

Empirical Asset Management increased its Charles River Laboratories (CRL) stake by 0.46% in Q2 2026, buying an estimated $1.25K and bringing the position to 1,515 shares worth $344K. The position accounts for 0.08% of the portfolio, ranked #290.

Empirical Asset Management first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $406K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Empirical Asset Management held 1,515 shares of Charles River Laboratories worth $344K as of Q2 2026.
Empirical Asset Management bought 7 Charles River Laboratories shares in Q2 2026, an estimated $1.25K.
Charles River Laboratories made up 0.08% of Empirical Asset Management's portfolio in Q2 2026, its #290 holding.
Empirical Asset Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
Empirical Asset Management's Charles River Laboratories position peaked at $406K in Q1 2024.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.